Peripheral Nerve Stimulation for Treatment of Sacroiliac Joint Pain

NCT ID: NCT05357300

Last Updated: 2022-05-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-26

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective randomized controlled study, primary objective: Pain reduction in patients with chronic Sacroiliac joint pain after therapy either with Peripheral Nerve Stimulation or with best medical treatment.

Randomization 4:3 to operative (PNS=Peripheral Nerve Stimulation) arm or conservative (BMT= Best Medical Treatment) arm with crossover possibility for the BMT group after 6 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sacroiliac Joint Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Evaluation of the pain reduction in patients treated with peripheral nerve stimulation compared to best medical treatment
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Peripheral Nerve Stimulation

Implant of percutaneous leads and impulse generator for peripheral nerve stimulation

Group Type ACTIVE_COMPARATOR

Peripheral Nerve Stimulation

Intervention Type DEVICE

Implant of percutaneous leads for peripheral nerve stimulation of the rami dorsales of the SIJ and gluteal or abdominal implant of impulse generator

Best Medical Treatment

Physical therapy and therapy with analgetic medication

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Peripheral Nerve Stimulation

Implant of percutaneous leads for peripheral nerve stimulation of the rami dorsales of the SIJ and gluteal or abdominal implant of impulse generator

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is at least 18 years old
* Subject with chronic sacroiliac joint pain refractory to conservative treatment
* Subject with NRS of at least 60/100
* Subject with temporary pain reduction of at least 50% (NRS) after fluoroscopy guided SIJ infiltration
* Subject received conservative treatment for at least three months including physiotherapy and pain medication
* Subject is able to understand the study and Impulse generator programming

Exclusion Criteria

* Pregnancy
* Subject is under age
* Acute traumatic injury of the ISG
* Active inflammation or neoplastic infiltration of the SIJ
* Neoplastic diseases of the spine
* Spinal surgery within the last three months
* The SIJ pain is not the leading symptom
* Contraindication for Neuromodulation Device (severe psychiatric disease, severe coagulation disorder, acute infection, active autoimmune disease with immunosupression)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

PD Dr. med. Simon Bayerl

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

PD Dr. med. Simon Bayerl

PD Dr. med.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Simon H Bayerl, MD

Role: PRINCIPAL_INVESTIGATOR

Charite University, Berlin, Germany

Dimitri Tkatschenko, MD

Role: PRINCIPAL_INVESTIGATOR

Charite University, Berlin, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Charité - Universitätsmedizin Berlin, Department of Neurosurgery

Berlin, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Simon H Bayerl, MD

Role: CONTACT

+49 (0)30 450 560789

Dimitri Tkatschenko, MD

Role: CONTACT

+49 (0)30 450 560789

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Simon H Bayerl, MD

Role: primary

+49(0)30 450560789

Dimitri Tkatschenko, MD

Role: backup

+49(0)30 450560789

References

Explore related publications, articles, or registry entries linked to this study.

Stinson LW Jr, Roderer GT, Cross NE, Davis BE. Peripheral Subcutaneous Electrostimulation for Control of Intractable Post-operative Inguinal Pain: A Case Report Series. Neuromodulation. 2001 Jul;4(3):99-104. doi: 10.1046/j.1525-1403.2001.00099.x.

Reference Type BACKGROUND
PMID: 22151653 (View on PubMed)

van Balken MR, Vandoninck V, Messelink BJ, Vergunst H, Heesakkers JP, Debruyne FM, Bemelmans BL. Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain. Eur Urol. 2003 Feb;43(2):158-63; discussion 163. doi: 10.1016/s0302-2838(02)00552-3.

Reference Type BACKGROUND
PMID: 12565774 (View on PubMed)

Al Khalili Y, Jain S, Lam JC, DeCastro A. Brachial Neuritis. 2024 Feb 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK499842/

Reference Type BACKGROUND
PMID: 29763017 (View on PubMed)

Sargut TA, Tkatschenko D, Fruh A, Tuttenberg J, Heckert A, Fleck S, Kuckuck A, Bayerl SH. Study protocol for a prospective, randomized, multicenter trial to investigate the influence of peripheral nerve stimulation on patients with chronic sacroiliac joint syndrome (SILENCING). Trials. 2024 Mar 28;25(1):223. doi: 10.1186/s13063-024-08067-z.

Reference Type DERIVED
PMID: 38549128 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

128236

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

RFN for SIJ Disease Study
NCT01726608 COMPLETED PHASE4